We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$157M |
| 3 |
Amazon
AMZN
|
+$75.7M |
| 4 |
Tesla
TSLA
|
+$50M |
| 5 |
GE HealthCare
GEHC
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$33M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$17M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Relmada Therapeutics
RLMD
$527M
| $85K | ﹤0.01% |
37,635
+1,092
| +3% | +$3.77K |
|
|
DOMA
2877
DELISTED
Doma Holdings, Inc.
DOMA
| $84K | ﹤0.01% |
8,239
+74
| +0.9% | +$995 |
|
2878
Focus Universal
FCUV
$3.65M
| $83K | ﹤0.01% |
83
+2
| +2% | +$2.89K |
|
|
EXPR
2879
DELISTED
Express, Inc.
EXPR
| $83K | ﹤0.01% |
5,257
+218
| +4% | +$4.4K |
|
|
THRN
2880
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $81K | ﹤0.01% |
17,441
+716
| +4% | +$3.15K |
|
2881
Priority Technology Holdings
PRTH
$444M
| $80K | ﹤0.01% |
22,299
+283
| +1% | +$1.21K |
|
2882
Ondas Inc
ONDS
$5.19B
| $79K | ﹤0.01% |
72,790
+2,376
| +3% | +$4.14K |
|
2883
Viant Technology
DSP
$265M
| $77K | ﹤0.01% |
17,589
+89
| +0.5% | +$385 |
|
|
MAPS
2884
DELISTED
WM TECHNOLOGY INC A
MAPS
| $77K | ﹤0.01% |
90,815
+1,812
| +2% | +$1.95K |
|
2885
The Beachbody Company
BODI
$74.8M
| $77K | ﹤0.01% |
3,177
+18
| +0.6% | +$557 |
|
|
LVOX
2886
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $77K | ﹤0.01% |
24,793
+1,075
| +5% | +$2.85K |
|
2887
Aveanna Healthcare
AVAH
$2.07B
| $76K | ﹤0.01% |
73,120
+1,350
| +2% | +$1.6K |
|
2888
Transocean
RIG
$5.82B
| $75K | ﹤0.01% |
11,810
-1,974
| -14% | -$12.7K |
|
2889
Inseego
INSG
$90.5M
| $74K | ﹤0.01% |
12,722
-6
| -0% | -$53 |
|
2890
Finance of America Companies
FOA
$198M
| $72K | ﹤0.01% |
5,769
+199
| +4% | +$3.04K |
|
|
BRDS
2891
DELISTED
Bird Global, Inc.
BRDS
| $72K | ﹤0.01% |
10,319
-95
| -0.9% | -$493 |
|
|
KORE
2892
DELISTED
KORE Group Holdings
KORE
| $71K | ﹤0.01% |
11,577
+518
| +5% | +$4.38K |
|
2893
Instil Bio
TIL
$50.3M
| $70K | ﹤0.01% |
5,323
+111
| +2% | +$1.64K |
|
|
NEUE
2894
DELISTED
NeueHealth
NEUE
| $66K | ﹤0.01% |
3,763
+28
| +0.7% | +$1.44K |
|
|
TRML
2895
DELISTED
Tourmaline Bio
TRML
| $65K | ﹤0.01% |
3,442
+20
| +0.6% | +$330 |
|
|
PRDS
2896
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $65K | ﹤0.01% |
49,055
+2,527
| +5% | +$4.13K |
|
2897
Arena Group
AREN
$83.8M
| $61K | ﹤0.01% |
14,456
+227
| +2% | +$1.72K |
|
2898
TeraWulf
WULF
$8.52B
| $61K | ﹤0.01% |
65,169
+38,092
| +141% | +$28.4K |
|
2899
Palladyne AI
PDYN
$296M
| $61K | ﹤0.01% |
21,272
+530
| +3% | +$1.85K |
|
|
BBBY
2900
DELISTED
Bed Bath & Beyond Inc
BBBY
| $60K | ﹤0.01% |
140,173
-100,587
| -42% | -$207K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
- RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
- RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
- RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
- RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
- RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.
Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.